Results of SARC 022, a phase II multicenter study of linsitinib in pediatric and adult wild-type (WT) gastrointestinal stromal tumors (GIST).
Margaret von Mehren
Consultant or Advisory Role - Novartis; Pfizer
Honoraria - Novartis
Research Funding - NCI
Suzanne George
Consultant or Advisory Role - ARIAD; Bayer; Novartis; Pfizer
Research Funding - ARIAD; Bayer; Novartis; Pfizer
Michael C. Heinrich
Consultant or Advisory Role - ARIAD; MolecularMD; Novartis; Pfizer
Honoraria - Novartis; Onyx
Research Funding - ARIAD; Novartis
Scott Schuetze
No relevant relationships to disclose
Martin G. Belinsky
Research Funding - NCI; Sarcoma Foundation of America
Katherine A. Janeway
Consultant or Advisory Role - Pfizer (U)
Lori Rink
Research Funding - NCI
Kristen N. Ganjoo
No relevant relationships to disclose
Jian Qin Yu
Research Funding - NCI
Jeffrey T. Yap
Research Funding - NCI
John Joseph Wright
No relevant relationships to disclose
Annick D. Van Den Abbeele
Research Funding - NCI